IRCT20200720048139N1招募中2 期
Investigating effect of Spirulina (Arthrospira platensis) dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units of hospitals: phase 2 clinical trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 138
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •All covid-19 patients confirmed with PCR test admitted to the ICU are entered the trial
排除标准
- •Age less than 18
- •Women during pregnancy and lactation
- •Consumers of supplements C, E, Omega 3, Antioxidants in the last 3 months
- •Patients with severe renal failure
- •Patients with liver failure last stage (cirrhosis)
- •Patients with uncontrolled hypertension
- •Patients who do not have a functioning gastrointestinal tract and have not been prescribed oral or intravenous nutrition
- •Patients with drug / food allergies
研究者
相似试验
已完成
不适用
Effects of Spirulina supplementation on ulcerative colitis patientsIRCT20191204045612N1Esfahan University of Medical Sciences80
招募中
2 期
Complementary effect of spirulina in the treatment of opioid patients under methadone maintenance treatmentAddiction.Other psychoactive substance related disordersIRCT20231101059923N2Kashan University of Medical Sciences50
招募中
3 期
Evaluation of the effect of spirulina extract on patients with coronavirusCOVID-19.Covid-19 infectionU07.1IRCT20200330046897N1Ahvaz University of Medical Sciences105
已完成
3 期
Spirulina in covid 19Covid19,Virus identified.COVID19 , Virus identifiedU07.1IRCT20101201005287N4Tabriz University of Medical Sciences100
招募中
不适用
effect of Spirulina in nonalcoholic fatty liver diseaseonalcoholic Fatty Liver Disease.Other specified inflammatory liver diseasesK75.8IRCT20110510006431N5Shahid Beheshti University of Medical Sciences50